A detailed study of the effects of global
myocardial ischemia and reperfusion on
inositol phosphate release and metabolism has been undertaken by using isolated perfused rat hearts.
Ischemia for longer than 5 minutes caused a cessation of
inositol phosphate production, with
inositol phosphates initially present accumulating as isomers of
inositol monophosphate. This inhibition was independent of
norepinephrine. In contrast, 2-minute reperfusion following 20-minute
ischemia produced a rapid and transient release of
inositol phosphates that was dependent on the release of
norepinephrine and mediated by alpha 1-adrenergic receptors. By a number of criteria, this reperfusion response was different from the
norepinephrine response in normoxic tissue. First, total release of
inositol phosphates was greater (466 +/- 37 compared with 345 +/- 29 cpm/mg
protein, P < .05). Second,
inositol 1,4,5-trisphosphate was released with postischemic reperfusion (103 +/- 18 to 207 +/- 11 pmol/mg
protein), whereas release was not detected in normoxic myocardium. In agreement with this,
neomycin (0.5 and 5 mmol/L) inhibited
inositol phosphate release only under reperfusion conditions. Third, the reperfusion response, unlike the response in nonischemic tissue, required extracellular Ca2+. Longer periods of reperfusion resulted in a return to a pattern of
inositol phosphate release that was not different from that seen in normoxic tissue. The rapid and transient release of
inositol 1,4,5-trisphosphate at 2-minute postischemic reperfusion provides an explanation for the enhanced role of alpha 1-adrenergic receptors under these conditions and suggests an important role for this compound in initiating reperfusion-induced pathological events.